The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats

Brain Research

Volumn 826, Issue 2, 1999, Pages 200-209

  Gambarana, Carla ^a   Ghiglieri, Ombretta ^a   Masi, Flavio ^a   Scheggi, Simona ^a   Tagliamonte, Alessandro ^a   De Montis, Maria Graziella ^b  

^a Pharmacology Unit   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Dopamine; Escape deficit; Lithium; Microdialysis; Rubidium; Stress

Indexed keywords

DOPAMINE; LITHIUM; RUBIDIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; MALE; MICRODIALYSIS; NOCICEPTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; ANTIMANIC AGENTS; BRAIN CHEMISTRY; CHLORIDES; CHRONIC DISEASE; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; ESCAPE REACTION; LITHIUM CHLORIDE; MALE; MICRODIALYSIS; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RUBIDIUM; STRESS;

EID: 0033135856     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01286-X     Document Type: Article

References (37)

1. Aulakh C.S., Hill J.L., Murphy D.L. Enhanced anorexic responses to m-chlorophenylpiperazine during lithium administration to fawn-hooded rats. Pharmacol. Biochem. Behav. 49:1994;759-762.
2. Bourin M., Hascoet M., Colombel M.C., Redrobe J.P., Baker G.B. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems. Eur. Neuropsychopharmacol. 6:1996;231-236.
3. 86 as a tracer of potassium in man with and without heart failure. J. Lab. Clin. Med. 45:1955;371-393.
4. Carrol B.J., Sharp P.T. Rubidium and lithium: opposite effects on amine-mediated excitement. Science. 172:1971;1355-1357.
5. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
6. De Montis M.G., Gambarana C., Ghiglieri O., Tagliamonte A. Reversal of stable behavioural modifications through NMDA receptor inhibition in rats. Behav. Pharmacol. 6:1995;562-567.
7. 3H ] dopamine uptake by flunarizine Eur. J. Pharmacol. 203:1991;67-69.
8. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
9. Eddy N.B., Leimbach D. Synthetic analgesics: II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-393.
10. Eichelman B., Thoa N.B., Perez-Cruet J. Alkali metal cations: effects on aggression and adrenal enzymes. Pharmacol. Biochem. Behav. 1:1973;121-123.
11. Faria M.S., Teixeira N.A. Reversal of learned helplessness by chronic lithium treatment at a prophylactic level. Braz. J. Med. Biol. Res. 26:1993;1201-1212.
12. Fieve R.R., Meltzer H., Dunner D.L., Levitt M., Mendlewicz J., Thomas A. Rubidium: biochemical, behavioral and metabolic studies in humans. Am. J. Psychiatry. 130:1973;55-61.
13. Gambarana C., Ghiglieri O., Taddei I., Tagliamonte A., De Montis M.G. Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action. Behav. Pharmacol. 6:1995;66-73.
14. 1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine. Prog. Neuro-Psych. Biol. Psych. 19:1995;741-755.
15. C. Gambarana, F. Masi, A. Tagliamonte, S. Scheggi, O. Ghiglieri, M.G. De Montis, A chronic stress which impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study, J. Neurochem. 1999, in press.
16. Geoffroy M., Tvede K., Christensen A.V., Schou J.S. The effect of imipramine and lithium on 'learned helplessness' and acetylcholinesterase in rat brain. Pharmacol. Biochem. Behav. 38:1991;93-97.
17. Ghiglieri O., Gambarana C., Scheggi S., Tagliamonte A., Willner P., De Montis M.G. Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress. Behav. Pharmacol. 8:1997;619-628.
18. Hines G. Effects of lithium on shock-induced changes in open-field activity. Psychopharmacology. 88:1986;209-212.
19. Hurd Y., Ungerstedt U. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse. 3:1989;48-54.
20. Johnson F.N. Effects of alkali metal chlorides on activity in rats. Nature. 238:1972;333-334.
21. L. Kersten, The gastrointestinal system, in: F.N. Johnson (Ed.), Depression and Mania. Modern lithium therapy, IRL Press, Oxford, 1987, pp. 196-201.
22. Krueger B.K. Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 55:1990;260-267.
23. 134 as tracers of potassium in the study of cation metabolism of human erythrocytes in vitro. J. Lab. Clin. Med. 41:1953;351-362.
24. Meltzer H.L. A pharmacokinetic analysis of long-term administration of rubidium chloride. J. Clin. Pharmacol. 31:1991;179-184.
25. H.L. Meltzer, Biochemical and physiological guidelines for long-term rubidium therapy, in: G.F. Placidi, L. Dell'Osso, G. Nisticò, H.S. Akiskal (Eds.), Recurrent mood disorders, Springer, Berlin, 1993, pp. 214-224.
26. Meltzer H.L., Taylor R.M., Platmann S.R., Fieve R.R. Rubidium: a potential modifier of affect and behaviour. Nature. 223:1969;321-322.
27. Nixon M.K., Hascoet M., Bourin M., Colombel M.C. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology. 115:1994;59-64.
28. Overstreet D.H. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17:1993;51-68.
29. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
30. Pei Q., Leslie R.A., Grahame-Smith D.G., Zetterstrom T.S. 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration. Neuroreport. 6:1995;716-720.
31. Placidi G., Lenzi A., Lazzerini F., Dell'Osso L., Cassano G.B., Akiskal H.S. Exploration of the clinical profile of rubidium chloride in depression: a systemic open trial. J. Clin Psychopharmacol. 8:1988;184-188.
32. R.I. Poust, Kinetic and tissue distribution, in: F.N. Johnson (Ed.), Depression and Mania. Modern Lithium Therapy, IRL Press, Oxford, 1987, pp. 73-74.
33. A. Spinedi, L. Pacini, P. Luly, G. Nisticò, Rubidium shows different effects from lithium on phosphatidylinositol metabolism in a cell line of human neuroblastoma, in: G.F. Placidi, L. Dell'Osso, G. Nisticò, H.S. Akiskal (Eds.), Recurrent Mood Disorders: New Perspectives in Therapy, Springer, Berlin, 1993, pp. 225-231.
34. Stolk J.M., Conner R.L., Barchas J.D. Rubidium-induced increase in shock-elicited aggression in rats. Psychopharmacologia. 22:1971;250-260.
35. Syme G.J., Syme L.A. Inhibition of activity in rats by rubidium chloride. Psychopharmacology. 61:1979;227-229.
36. + treatment prevents behavioral depression in rats. Braz. J. Med. Biol. Res. 28:1995;1003-1007.
37. Woolfe G., McDonald A.D. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J. Pharmacol. Exp. Ther. 80:1944;300-307.